Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc weekly Stock Chart
GlaxoSmithKline plc
Index- P/E20.25 EPS (ttm)2.03 Insider Own0.20% Shs Outstand2.50B Perf Week0.56%
Market Cap102.73B Forward P/E13.53 EPS next Y3.04 Insider Trans0.00% Shs Float2.47B Perf Month1.78%
Income5.05B PEG2.28 EPS next Q0.62 Inst Own11.50% Short Float0.26% Perf Quarter3.65%
Sales39.22B P/S2.62 EPS this Y42.70% Inst Trans0.09% Short Ratio2.71 Perf Half Y5.30%
Book/sh2.04 P/B20.16 EPS next Y5.45% ROA6.60% Target Price44.33 Perf Year1.08%
Cash/sh2.12 P/C19.43 EPS next 5Y8.90% ROE94.50% 52W Range36.41 - 42.32 Perf YTD7.64%
Dividend1.89 P/FCF27.48 EPS past 5Y-7.40% ROI16.00% 52W High-2.81% Beta0.71
Dividend %4.60% Quick Ratio0.50 Sales past 5Y3.10% Gross Margin68.70% 52W Low12.96% ATR0.47
Employees95490 Current Ratio0.70 Sales Q/Q6.10% Oper. Margin18.20% RSI (14)54.86 Volatility0.70% 0.86%
OptionableYes Debt/Eq7.91 EPS Q/Q50.20% Profit Margin12.50% Rel Volume0.80 Prev Close40.96
ShortableYes LT Debt/Eq5.82 EarningsJul 31 BMO Payout80.40% Avg Volume2.37M Price41.13
Recom2.00 SMA201.00% SMA502.69% SMA2003.05% Volume1,908,145 Change0.42%
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-22-19 10:06AM  Can Allergan (AGN) Keep the Earnings Streak Alive in Q2? Zacks
Jul-21-19 09:05PM  PRESS DIGEST- Financial Times - July 22 Reuters
Jul-20-19 12:07PM  8 More Big Pharma Events in 2019 You Don't Want to Miss Motley Fool
06:00AM  GSK sets out strategy to double drug discovery success Financial Times
02:54AM  Why GlaxoSmithKline plc (LON:GSK) Could Have A Place In Your Portfolio Simply Wall St.
Jul-19-19 09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
Jul-18-19 11:11AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
Jul-17-19 09:59AM  Swiss agree to extradite Chinese scientist to U.S. on theft charges Reuters
Jul-16-19 10:51AM  Glaxo's Zejula Meets Goal in First-Line Ovarian Cancer Study Zacks
Jul-15-19 02:46PM  Biotech investors Wellington, RA Capitals new funds top $700 million American City Business Journals
08:59AM  Gilead-Galapagos Ink $5.1B Deal for Additional Compounds Zacks
08:27AM  GSK drug helps ovarian cancer patients live longer in late-stage study Reuters
07:00AM  AI Drug Hunters Could Give Big Pharma a Run for Its Money Bloomberg
04:02AM  Ovarian cancer treatment boosts GSK Financial Times
02:52AM  UPDATE 2-GSK drug helps ovarian cancer patients live longer in late-stage study Reuters
Jul-14-19 09:10PM  PRESS DIGEST- Financial Times - July 15 Reuters
02:41PM  GSK in talks to name HSBC's Symonds as its next chairman: Bloomberg Reuters
12:35AM  GSK to appoint Jonathan Symonds as chairman Financial Times
Jul-12-19 08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
Jul-10-19 05:40PM  Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill Zacks
04:09PM  DNA Test Service Exposed Thousands of Client Records Online Bloomberg
01:18PM  GSK's two-drug HIV Dovato treatment meets main goal in study Reuters
11:21AM  Companies to Watch: T-Mobile joins S&P 500, Tesla to ramp up production, Marriott faces lawsuit Yahoo Finance
10:15AM  Study: ViiV Healthcare's 2-Drug HIV Regimen As Effective As 3 Benzinga
09:49AM  UPDATE 2-GSK's two-drug HIV Dovato treatment meets main goal in study Reuters
03:20AM  CORRECTED-UPDATE 1-GSK's Dovato suppresses AIDS virus at same levels of 3-drug regimen Reuters
02:35AM  GSK's Dovato meets primary goal in late-stage HIV study Reuters
Jul-09-19 10:06AM  Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status Zacks
Jul-08-19 07:54AM  U.S. seeks extradition of Chinese researcher in drug secrets theft Reuters
06:00AM  U.S. seeks extradition of Chinese researcher in drug secrets theft Reuters
Jul-05-19 09:32AM  Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs Zacks
Jul-04-19 10:26AM  Glaxo's Dovato Wins EU Nod, RA Candidate Enters Phase III Zacks
Jul-03-19 01:54PM  Roche's Flu Medicine Xofluza Meets Goal in Study on Kids Zacks
01:40PM  5 Dividend Stocks to Buy From Across the Globe InvestorPlace
07:31AM  The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief Benzinga
04:21AM  GSK's HIV drug receives EU marketing nod Reuters
Jul-02-19 02:34PM  GSK hikes price of subsidiary Tesaro's ovarian cancer drug American City Business Journals
09:34AM  Drugmakers raise prices of crucial drugs Yahoo Finance Video
09:06AM  GSK-Pfizer JV gets conditional approval from S.Africa's competition regulator Reuters
09:01AM  AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label Zacks
Jun-28-19 09:44AM  Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger Zacks
Jun-26-19 06:24AM  Gilead Inks Deal With Carna Biosciences for Immuno-Oncology Zacks
Jun-25-19 10:40AM  Primary Drivers of the Chinese Economy Investopedia
Jun-21-19 09:20AM  Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up Zacks
Jun-20-19 09:18AM  AstraZeneca's Triple-Combo COPD Inhaler Gets Japan's Nod Zacks
07:40AM  5 Undervalued Stocks to Buy InvestorPlace
06:33AM  Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs Zacks
04:18AM  GSK offers concessions to address EU concerns over Pfizer deal Reuters
Jun-19-19 01:37PM  GSK kicks off sale of $1.2 billion consumer health drugs: sources Reuters
10:21AM  Merck's Keytruda Gets 2nd Label Expansion Approval in June Zacks
Jun-18-19 10:30AM  Sanofi Partners Google to Build Healthcare Innovation Lab Zacks
08:59AM  AstraZeneca/Merck's Lynparza Wins EU Nod for First-Line Use Zacks
Jun-17-19 11:02AM  GSK pharma head flags need for speed in high-pressure drug market Reuters
10:08AM  Health Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and more American City Business Journals
09:30AM  Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth Bloomberg
06:33AM  UPDATE 2-VBI's shares plunge after hep B vaccine fails secondary goal in late-stage trial Reuters
06:09AM  VBI hepatitis B vaccine meets main goals in late-stage trial Reuters
Jun-14-19 03:42PM  Heres What Hedge Funds Think About GlaxoSmithKline plc (GSK) Insider Monkey
09:00AM  Glaxo Inks Genome Research Deal With University of California Zacks
Jun-13-19 08:36PM  PRESS DIGEST- Financial Times - June 14 Reuters
04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
08:21AM  GSK links up with US university on genome research Financial Times
Jun-12-19 09:33PM  Edited Transcript of GSK.L earnings conference call or presentation 25-Oct-17 1:00pm GMT Thomson Reuters StreetEvents
Jun-07-19 04:01AM  Germany's Stada buys six of GSK's consumer brands, eyes further deals Reuters
Jun-06-19 05:15PM  Nucala (mepolizumab) Gains FDA Approval for Two New Self-Administration Options Business Wire
08:15AM  Better Buy: GlaxoSmithKline vs. Merck Motley Fool
Jun-05-19 09:09AM  Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options Zacks
Jun-04-19 11:52AM  Emergent (EBS) Wins HHS Contract to Supply VIGIV Product Zacks
10:09AM  Trump strikes "supportive" tone in meeting with British business leaders -sources Reuters
Jun-03-19 08:17PM  PRESS DIGEST- British Business - June 4 Reuters
05:30PM  Let's deepen economic ties, Britain's May tells Trump Reuters
08:05AM  Matinas BioPharma to Present at the 9th Annual LD Micro Invitational GlobeNewswire
May-28-19 04:02PM  Gilead Gains 6.8% YTD as HIV Franchise Maintains Momentum Zacks
May-27-19 05:55AM  Glaxo's Shingles Vaccine Shingrix Gets Approval in China Zacks
May-24-19 09:30AM  Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates Zacks
May-23-19 01:10PM  GSK gets approval for Shingles vaccine in China American City Business Journals
01:09PM  GSK brings back bonuses for some sales reps Reuters
12:59PM  GSK's shingles vaccine approved for use in China in adults aged 50 and above Reuters
10:31AM  GSK to change incentives for sales representatives Reuters
09:00AM  Better Buy: Johnson & Johnson vs. GlaxoSmithKline Motley Fool
03:14AM  GlaxoSmithKline revamps incentives for sales representatives Financial Times
12:00AM  3 Top Stocks With High Dividend Yields Motley Fool
May-21-19 08:46AM  Merck's Keytruda Fails in Late-Stage Breast Cancer Study Zacks
08:13AM  Merck agrees $1bn deal to buy biopharmaceutical company Peloton Financial Times
07:08AM  Edited Transcript of GSK.L earnings conference call or presentation 1-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-17-19 09:13AM  Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site Zacks
02:14AM  GSK and Novartis liniment marketing misled Australian consumers - court Reuters
May-16-19 11:49AM  How to Invest in Biotech: Known Your Catalysts
05:00AM  Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK PR Newswire
May-15-19 07:00AM  Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates GlobeNewswire
May-14-19 02:02AM  Stanford Dad Accused of $6.5 Million Payment in College Scandal Has a New Problem Bloomberg
May-12-19 11:00AM  Top vaccine makers Merck and Pfizer target China and older adults next CNBC
10:02AM  The money behind vaccines CNBC Videos
May-08-19 09:37PM  GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
09:02PM  Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal Reuters
11:44AM  Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates Zacks
09:46AM  Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong Zacks
May-07-19 04:54PM  What's in Store for Axsome (AXSM) This Earnings Season? Zacks
May-06-19 09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
May-04-19 01:09PM  UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S Reuters
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. It has collaboration agreements with 23andMe; Liquidia Technologies, Inc.; and SpringWorks Therapeutics, Inc., as well as a strategic alliance with Merck KGaA. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorJul 01Buy15.00333,3334,999,9952,633,772Jul 02 04:13 PM
GLAXOSMITHKLINE PLCDirectorMay 28Buy14.00385,7145,399,9961,915,275May 30 05:47 PM
GLAXOSMITHKLINE PLCDirectorApr 22Buy18.00325,0005,850,0001,992,550Apr 24 07:28 PM
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM